5WXB
crystal structure of ZIKV MTase in complex with SAH
5WXB の概要
エントリーDOI | 10.2210/pdb5wxb/pdb |
分子名称 | MRNA cap 0-1 NS5-type MT, S-ADENOSYL-L-HOMOCYSTEINE (3 entities in total) |
機能のキーワード | zika virus, methyltransferase, sah, transferase |
由来する生物種 | Zika virus (strain Mr 766) (ZIKV) |
細胞内の位置 | Virion membrane ; Multi-pass membrane protein : A0A167V0D5 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 29746.96 |
構造登録者 | |
主引用文献 | Zhou, H.,Wang, F.,Wang, H.,Chen, C.,Zhang, T.,Han, X.,Wang, D.,Chen, C.,Wu, C.,Xie, W.,Wang, Z.,Zhang, L.,Wang, L.,Yang, H. The conformational changes of Zika virus methyltransferase upon converting SAM to SAH Oncotarget, 8:14830-14834, 2017 Cited by PubMed Abstract: An outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly potentially associated with ZIKV infection has already caused a public health emergency of international concern. Currently, there are no clinically effective vaccines or antiviral drugs available to treat ZIKV infection. The methyltransferase domain (MTase) of ZIKV nonstructural protein 5 (NS5) can sequentially methylate guanine N-7 and ribose 2'-O to form m7NGpppA2'Om cap structure in the new RNA transcripts. This methylation step is crucial for ZIKV replication cycle and evading the host immune system, making it a target for drug design. Here, we present the 1.76 Å crystal structure of ZIKV MTase in complex with the byproduct SAH, providing insight into the elegant methylation process, which will benefit the following antiviral drug development. PubMed: 28122329DOI: 10.18632/oncotarget.14780 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.762 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード